About SURVIVEiT

Our mission is to empower you to define your journey and face cancer on your own terms.

Our vision is a world free from the fear of cancer.

SURVIVEiT is a registered 501(c)(3) nonprofit organization. EIN 46-3365665

What do we do?

We work to facilitate informed-decision making. Through experience-based wisdom, we guide, teach, and support you to define and navigate your chosen path to face cancer with hope.

How do we do it?

We cut through the noise to help you navigate the convoluted process of managing the disease. The SURVIVEiT® Cancer Navigation Tool offers best-in-class resources and objective information in a personalized, easy-to-use tool from the moment of diagnosis. Our hope is that it helps you as you make critical decisions and seek the best outcomes possible.

Why does it matter?

Everything we do is guided by the wisdom and urgency that can only come from having faced cancer ourselves. We are constantly. moved to help empower you and others to define your journeys and face cancer fearlessly.

Meet Our SURVIVEiT Leadership Team

EXECUTIVE DIRECTOR

Joy Brewster Rusthoven

Executive Director

EXECUTIVE BOARD OF DIRECTORS

Steve_Mix
Tina Trenkler
Amundson_Paul_-_20131101
Matt_Smith_photo

Learn more about our Councils, Committees, and Boards.

Dr. Christopher Lieu, MD

Dr. Lieu joined the University of Colorado School of Medicine faculty in July 2011.  He trained in internal medicine at the University of Colorado, where he served as a Chief Medical Resident.  He completed his fellowship training in medical oncology at the University of Texas MD Anderson Cancer Center and also served as the Chief Medical Oncology Fellow.  Dr. Lieu is the Associate Director for Clinical Research and Director of GI Medical Oncology at the University of Colorado Cancer Center, the Vice-Chair of the National Cancer Institute Colon Cancer Task Force, and he serves on the National Comprehensive Cancer Network (NCCN) Panel for Neuroendocrine Cancers.

Research

Dr. Lieu is a member of the Developmental Therapeutics (phase I clinical trials) and Gastrointestinal (GI) Medical Oncology Program.   These comprehensive programs include multidisciplinary cancer clinics, tumor boards, and research endeavors.  Dr. Lieu is interested in resistance mechanisms to targeted therapy in GI cancers, and he was awarded the Conquer Cancer Foundation Career Development Award, NIH K23 grant, and a NIH R01 grant to study targeted therapies in colorectal cancer.  Dr. Lieu is also investigating novel therapeutic strategies to more effectively treat and prevent colorectal cancer in young adults.

Thank you to our supporters!

bms_logo_rgb_pos_300
Takeda_Oncology_horizontal
Foundation Medicine logo_horiz
Logo
Pfizer_logo